Fig. 3From: MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumorsDistribution of methylation levels of microRNAs according to Gleason score and pathological stage in the series of patients submitted to radical prostatectomy (Cohort #1)Back to article page